Innoskel vs National Organization for Rare Disorders

Innoskel logo

Innoskel

Developing novel therapies for rare bone diseases

2 employees · est. 2020 · France

VS
National Organization for Rare Disorders logo

National Organization for Rare Disorders

Alone we are rare. Together we are strong.®

176 employees · est. 1983 · Danbury, United States

National Organization for Rare Disorders is the older company (2020 vs 1983); National Organization for Rare Disorders is the larger of the two.

Side-by-Side Comparison

Innoskel National Organization for Rare Disorders
Founded
2020 1983 older
Headquarters
France Danbury, United States
Employees
2 176 larger
Industry
Biotechnology, Health and Wellness Health Care
Funding Stage
Series A Not tracked yet
Total Funding
$20.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Online retail of a wide range of products including electronics, fashion, beauty and health, home and lifestyle, sports and outdoor, automotive, gaming, electronics accessories, media and books, and food and beverages. Not tracked yet
Target Customers
Consumers seeking a diverse range of products for online purchase across various categories. Not tracked yet
Taxonomy
Rare DiseasesTherapeutic DevelopmentType 2 CollagenopathiesGene TherapySkeletal DisordersProof-of-concept Studies +4 Rare DiseasesPatient AdvocacyOrphan Drug ActPatient Support ServicesMedical ResearchAdvocacy Organization +9
Website
innoskel.com rarediseases.org
Innoskel logo

About Innoskel

Innoskel is a biotechnology startup with the slogan "Developing novel therapies for rare bone diseases." Founded in 2020 and headquartered in France, the company is focused on developing therapies for rare bone diseases, particularly targeting type 2 collagenopathies, including Spondyloepiphyseal Dy...

National Organization for Rare Disorders logo

About National Organization for Rare Disorders

National Organization for Rare Disorders (NORD) is a non-profit organization founded in 1983 with a mission to support individuals with rare diseases and the organizations serving them. NORD, alongside its 330 patient organization members, is dedicated to advancing the identification, treatment, and...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Innoskel and National Organization for Rare Disorders for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Innoskel or National Organization for Rare Disorders moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Innoskel was founded in 2020, based in France, with 2 employees. Innoskel is a biotechnology startup with the slogan "Developing novel therapies for rare bone diseases." Founded in 2020 and headquartered in France, the company is focused on developing therapies for. National Organization for Rare Disorders was founded in 1983, based in Danbury, United States, with 176 employees. National Organization for Rare Disorders (NORD) is a non-profit organization founded in 1983 with a mission to support individuals with rare diseases and the organizations serving them. NORD, alongsid.
Innoskel has raised $20.00M and National Organization for Rare Disorders no disclosed funding. Latest stage: Innoskel Series A.
Both list rare diseases and medical research among their focus areas.

Compare Innoskel with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Innoskel on 7 Jun 2025, and National Organization for Rare Disorders on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes